David I Feldman
Overview
Explore the profile of David I Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Fudim M, Feldman D, Sayed A
J Card Fail
. 2024 Aug;
31(2):489-491.
PMID: 39168235
The growth of digital health technology has led to innovative technological solutions that can help to improve patient care. However, the primary focus to date has been on the passive...
3.
Feldman D, Babikian S, Feldman T, Curnow R, Fudim M
J Card Fail
. 2024 May;
30(9):1166-1169.
PMID: 38740175
No abstract available.
4.
Dudum R, Dardari Z, Feldman D, Berman D, Budoff M, Miedema M, et al.
Am J Cardiol
. 2023 Jan;
191:76-83.
PMID: 36645939
Coronary artery calcium (CAC) measures subclinical atherosclerosis and improves risk stratification. CAC characteristics-including vessel(s) involved, number of vessels, volume, and density-have been shown to differentially impact risk. We assessed how...
5.
Nasir K, Ziffer J, Cainzos-Achirica M, Ali S, Feldman D, Arias L, et al.
Am J Prev Cardiol
. 2021 Oct;
7:100202.
PMID: 34611641
Objective: The Miami Heart Study (MiHeart) at Baptist Health South Florida is an ongoing, community-based, prospective cohort study aimed at characterizing the prevalence, characteristics, and prognostic value of diverse markers...
6.
Feldman D, Latina J, Lovell J, Blumenthal R, Arbab-Zadeh A
Trends Cardiovasc Med
. 2021 Aug;
32(7):421-428.
PMID: 34454051
The treatment of coronary artery disease (CAD), which is defined by stable anatomical atherosclerotic and functional alterations of epicardial vessels or microcirculation, focuses on managing intermittent angina symptoms and preventing...
7.
Varghese B, Feldman D, Chew C, Valilis E, Blumenthal R, Sharma G, et al.
Heart Rhythm O2
. 2021 Aug;
2(3):298-303.
PMID: 34337581
Increasing evidence suggests that the "NACHT-LRR and PYD domain-containing protein 3" (NLRP3) inflammasome plays an important role in atherosclerotic cardiovascular disease (ASCVD). Recent preclinical evidence has suggested that the NLRP3...
8.
Feldman D, Wu K, Hays A, Marvel F, Martin S, Blumenthal R, et al.
Am J Prev Cardiol
. 2021 Jul;
6:100181.
PMID: 34327502
In recent years, improvement in outcomes related to cardiovascular disease is in part due to the prioritization and progress of primary and secondary prevention efforts. The Johns Hopkins Ciccarone Center...
9.
Feldman D, Michos E, Stone N, Gluckman T, Cainzos-Achirica M, Virani S, et al.
Am J Prev Cardiol
. 2021 Jul;
4:100117.
PMID: 34327477
In 2018, the AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol was released. Less than one year later, the 2019 ESC/EAS Dyslipidemia Guideline was published. While both provide important...
10.
Sharma G, Feldman D, Bittl J
JACC Cardiovasc Interv
. 2021 Jul;
14(13):1447-1449.
PMID: 34238554
No abstract available.